Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | (FY)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -295.42%-10.02M | ---- | 98.18%-2.53M | ---- | -459.66%-139.09M | ---- | -327.49%-24.85M | ---- | 204.20%10.93M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 14.84%-218K | ---- | -924.00%-256K | ---- | 85.96%-25K | ---- | 93.83%-178K | ---- | -131.33%-2.89M |
| Interest expense - adjustment | ---- | -19.35%1.5M | ---- | 528.38%1.86M | ---- | -14.45%296K | ---- | 13.07%346K | ---- | 123.36%306K |
| Dividend (income)- adjustment | ---- | ---- | ---- | 2.24%-349K | ---- | -91.94%-357K | ---- | -1,760.00%-186K | ---- | 9.09%-10K |
| Attributable subsidiary (profit) loss | ---- | 163.29%208K | ---- | --79K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 49.94%2.62M | ---- | -47.46%1.75M | ---- | -30.84%3.32M | ---- | 3,596.15%4.81M | ---- | -88.54%130K |
| -Impairment of property, plant and equipment (reversal) | ---- | --538K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 19.13%2.08M | ---- | -47.46%1.75M | ---- | -30.84%3.32M | ---- | 3,596.15%4.81M | ---- | -88.54%130K |
| Revaluation surplus: | ---- | ---- | ---- | -99.51%3K | ---- | 57.44%614K | ---- | 207.09%390K | ---- | --127K |
| -Other fair value changes | ---- | ---- | ---- | -99.51%3K | ---- | 57.44%614K | ---- | 207.09%390K | ---- | --127K |
| Asset sale loss (gain): | ---- | -1,467.01%-39.71M | ---- | ---2.53M | ---- | ---- | ---- | 1,450.00%27K | ---- | 98.47%-2K |
| -Loss (gain) from sale of subsidiary company | ---- | -1,285.14%-39.7M | ---- | ---2.87M | ---- | ---- | ---- | ---- | ---- | ---2K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -103.01%-10K | ---- | --332K | ---- | ---- | ---- | --27K | ---- | ---- |
| Depreciation and amortization: | ---- | 6.28%9.19M | ---- | 0.36%8.64M | ---- | 10.77%8.61M | ---- | 58.54%7.78M | ---- | 196.14%4.9M |
| Special items | ---- | -1,333.33%-43K | ---- | ---3K | ---- | ---- | ---- | ---45K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -647.97%-36.47M | ---- | 105.26%6.66M | ---- | -962.41%-126.63M | ---- | -188.33%-11.92M | ---- | 250.79%13.49M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 104.16%31K | ---- | 53.61%-746K | ---- | -130.04%-1.61M | ---- | -353.26%-699K | ---- | 201.10%276K |
| Accounts receivable (increase)decrease | ---- | 234.23%71.22M | ---- | -169.78%-53.06M | ---- | 190.60%76.04M | ---- | -938.96%-83.93M | ---- | -186.21%-8.08M |
| Accounts payable increase (decrease) | ---- | -170.15%-10.74M | ---- | 125.04%15.31M | ---- | -152.89%-61.16M | ---- | 469.59%115.64M | ---- | -12.56%-31.29M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | --4.15M | ---- | ---- | ---- | ---- | ---- | 52.38%32K |
| Special items for working capital changes | ---- | 241.56%17.06M | ---- | -118.43%-12.05M | ---- | 245.89%65.38M | ---- | -2,360.96%-44.81M | ---- | -108.75%-1.82M |
| Cash from business operations | -124.42%-2.45M | 193.64%41.09M | 125.18%10.04M | 8.53%-43.89M | -46.98%-39.88M | -86.53%-47.98M | -89.03%-27.13M | 6.08%-25.72M | 56.23%-14.35M | -301.91%-27.39M |
| Other taxs | ---- | -22.37%-93K | -164.29%-37K | -155.07%-76K | -16.67%-14K | -54.75%138K | 99.54%-12K | 108.45%305K | 27.92%-2.6M | 32.17%-3.61M |
| Dividend received - operating | ---- | ---- | ---- | -2.24%349K | 16.67%7K | 91.94%357K | -25.00%6K | 1,760.00%186K | -11.11%8K | -9.09%10K |
| Special items of business | ---- | ---- | ---- | --4.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -124.51%-2.45M | 203.89%41M | 125.08%10M | 16.89%-39.47M | -46.97%-39.89M | -88.20%-47.49M | -60.13%-27.14M | 18.57%-25.23M | 53.43%-16.95M | -155.57%-30.99M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -22.33%80K | -14.84%218K | -25.90%103K | 924.00%256K | 6,850.00%139K | -85.96%25K | -98.88%2K | -93.83%178K | -90.23%178K | 131.33%2.89M |
| Loan receivable (increase) decrease | ---- | ---- | ---324K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%54M |
| Sale of fixed assets | ---- | --10K | --10K | ---- | ---- | 536.54%331K | ---- | --52K | ---- | ---- |
| Purchase of fixed assets | 98.89%-9K | 57.68%-884K | -60.67%-813K | -58.86%-2.09M | -61.66%-506K | 47.53%-1.32M | 60.48%-313K | -716.29%-2.51M | -357.80%-792K | 93.26%-307K |
| Sale of subsidiaries | ---- | -27,460.00%-1.38M | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | --81K | ---- | ---- | ---2.83M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15M | --15M | ---- |
| Cash on investment | ---- | ---- | ---- | ---583K | ---- | ---- | ---- | 66.72%-4.99M | ---- | ---15M |
| Net cash from investment operations | 107.53%71K | 15.99%-2.03M | -156.95%-943K | 36.14%-2.42M | -18.01%-367K | -149.03%-3.79M | -102.16%-311K | -81.40%7.73M | -74.15%14.39M | 172.79%41.58M |
| Net cash before financing | -126.28%-2.38M | 193.03%38.97M | 122.51%9.06M | 18.31%-41.89M | -46.64%-40.25M | -193.02%-51.28M | -971.81%-27.45M | -265.16%-17.5M | -113.30%-2.56M | 115.30%10.6M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | -7.90%91.55M | 1,237.12%254.8M | 370.09%99.4M | --19.06M | --21.15M | ---- | ---- | ---- |
| Refund | ---- | 81.62%-39.57M | -97.07%-108.53M | -1,029.48%-215.23M | -160.44%-55.07M | ---19.06M | ---21.15M | ---- | ---- | ---- |
| Interest paid - financing | 92.15%-70K | 19.35%-1.5M | -72.87%-892K | -528.38%-1.86M | -111.48%-516K | 14.45%-296K | 41.06%-244K | -13.07%-346K | -225.98%-414K | -123.36%-306K |
| Absorb investment income | ---- | ---- | ---- | --1.87M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 93.24%-1.42M | -237.61%-47.84M | -150.52%-20.96M | 827.93%34.77M | 2,401.22%41.49M | 40.49%-4.78M | 69.73%-1.8M | -84.93%-8.03M | -188.47%-5.96M | -104.05%-4.34M |
| Effect of rate | ---- | 95.78%-19K | 45.74%137K | 46.36%-450K | -60.17%94K | -31.09%-839K | 266.20%236K | -329.53%-640K | -1,192.31%-142K | -7,350.00%-149K |
| Net Cash | 68.08%-3.8M | -24.62%-8.87M | -1,060.45%-11.9M | 87.30%-7.12M | 104.24%1.24M | -119.60%-56.05M | -243.41%-29.25M | -508.07%-25.53M | -149.55%-8.52M | -83.45%6.26M |
| Begining period cash | -21.45%32.56M | -15.44%41.45M | -15.44%41.45M | -53.72%49.02M | -53.72%49.02M | -19.81%105.91M | -19.81%105.91M | 4.85%132.08M | 4.85%132.08M | 42.88%125.97M |
| Cash at the end | -3.12%28.76M | -21.45%32.56M | -41.04%29.69M | -15.44%41.45M | -34.52%50.35M | -53.72%49.02M | -37.69%76.9M | -19.81%105.91M | -13.80%123.42M | 4.85%132.08M |
| Cash balance analysis | ||||||||||
| Bank deposits | ---- | ---- | ---- | ---- | -5.90%6.67M | ---- | 343.13%7.09M | ---- | -98.62%1.6M | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | -5.90%6.67M | ---- | 343.13%7.09M | ---- | -98.62%1.6M | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.